Skip to content
OpenCapital
Get started

Agilon Health AGL Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One

Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One at other companies

CVS Health logo
CVS HealthCVS
——
Clover Health Investments logo
Clover Health InvestmentsCLOV
——

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%—

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio1×-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one?
Agilon Health (AGL) reported debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one of $38.56M in Q1 2026.
How has Agilon Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one changed year-over-year?
Agilon Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, year one decreased by 69.7% year-over-year, from $127.29M to $38.56M.